Monitoring & metering
Using technology to fight the pandemic
Many of Vaisala’s products and systems provide a major contribution in the fight against communicable diseases, and this article outlines some of the vitally important ways in which the company’s technologies are helping fight the COVID-19 pandemic
E
ven before the coronavirus pandemic, health and well-being featured highly in the priorities of many organisations,
governments and citizens. This drove technology companies such as Vaisala to develop products that meet the demands of increasingly health conscious societies. Good Health and Well-Being is also one of the United Nations Sustainable Development Goals (SDG 3), which seeks to improve people’s health, increase life expectancy, reduce maternal and child mortality and fight communicable diseases. Vaisala has integrated the UN SDGs into its
strategic planning in order to contribute to sustainable development and find inspiration for the development of new business and sustainable business practices. Many of Vaisala’s products and systems provide a major contribution in the fight against communicable diseases, and in the following article, some of the vitally important ways in which the company’s technologies are helping fight the COVID-19 pandemic are outlined.
EnsurIng OptIMal COnDItIOns fOr COVID-19 VaCCInE DEVElOpMEnt The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19. The word COVID-19 represents Corona (CO) Virus (VI) Disease (D) and 19(2019) is the year that the first cases were detected in China’s Wuhan. Coronaviruses are enveloped viruses, first isolated in the 1960s from the nasal cavities of patients suffering with colds. It is believed that Coronaviruses are responsible for 10 to 15 per cent of colds worldwide, and have a seasonal pattern. As a new variant virus, SARS-CoV-2 spread
quickly and easily around the world, resulting in large numbers of deaths and causing enormous economic damage. With no approved treatment immediately available, the race is on to develop a
30
vaccine for COVID-19, and Vaisala provides a technology to support that mission. In March 2020 an express order was
received from Wuhan, China for the rapid delivery of GMP231 Carbon Dioxide Transmitters to monitor and control carbon dioxide levels in incubators. These incubators are used for the cultivation of microorganisms, such as a virus; the cultured virus is then used to help develop a vaccine. The main role of the GMP231 probes is to ensure that the carbon dioxide levels inside the incubators maintain the optimal pH level for cultivation.
tEChnOlOgy fOr ManagIng Drug anD VaCCInE ManufaCturE The Vaisala liquid measurements refractometer is used in drug development and in vaccine
August 2020 Instrumentation Monthly
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74
